Philips PACS interoperability helps Scotland’s National Health Service deliver leading breast cancer screening
16 Marzo 2022 - 03:00PM
Philips PACS interoperability helps Scotland’s National Health
Service deliver leading breast cancer screening
March 16, 2022
- Philips Vue PACS interoperability enhances access, quality of
care, and patient experience in Scottish Breast Screening
Program
- Image sharing across regional breast screening centers helps
better manage the post COVID-19 backlog of screening
appointments
Amsterdam, the Netherlands and Orlando, Florida, USA
– Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in
health technology, and NHS National Services Scotland, a
non-departmental public body that provides advice and services to
National Health Service (NHS) Scotland, today revealed the impact
of the COVID-19 pandemic on the Scottish Breast Screening Program
(SBSP), and the measures taken to deal with the backlog of delayed
appointments. Philips’ vendor-neutral Vue PACS (Picture Archiving
and Communication System) allows the SBSP’s six breast screening
centers and its mobile screening units to interoperate with
Scotland’s national PACS system, increasing access to breast
screening for Scotland’s rural communities, enhancing patient
choice, and streamlining diagnostic and treatment workflows.
Female breast cancer is the world’s most common form of cancer,
with approximately 2.26 million new cases in 2020 [1]. Nearly 1,000
women per year die from the disease in Scotland alone [2]. Through
the partnership between Philips and NHS National Services Scotland,
as many as 270,000 women in Scotland between the ages of 50 and 70
are invited for breast screening (mammography) every year [3].
However, according to Public Health Scotland (PHS), between April
2020 and December 2020 during the height of the COVID-19 pandemic,
there was a 19% fall in the number of women diagnosed with
early-stage breast cancer (down 35% at stage 1 and 15% at stage 2
diagnosis) [4]. This drop was largely attributed to the SBSP being
paused between March 30 and August 3, 2020, creating a backlog of
appointments, diagnoses, and treatments.
Philips Picture Archiving and Communication System (Vue PACS) is
a scalable and modular image management solution that provides
hospitals and related institutions with scalable (local and wide
area) PACS functionalities. The interoperability of Philips’ Vue
PACS has been a key factor in reducing that backlog, offering
enhanced connectivity between the screening program’s regional
screening centers, as well as interoperability with Scotland’s
Global PACS system.
“The national reporting function enabled by the Global PACS
solution allows centers to report and support each other. For
instance, in the case of a staffing issue due to absences from
sickness amongst readers, cases for reporting can rapidly pile up.
The use of this function allows readers from across Scotland to
provide mutual aid and assistance in ensuring all centers are at a
similar level in reporting,” said Dr. Gerald Lip, Clinical Director
of NE Scotland Breast Screening Service.
Streamlining workflows, improving access to better
careThe interoperability of Philips Vue PACS with
Scotland’s Global PACS system makes an individual patient’s current
and prior mammography images available to all NHS Scotland
hospitals, enabling clinicians to compare new scans with prior
studies irrespective of where they were performed in Scotland. It
also allows the program’s regional screening centers to support one
another - for example, when staff shortages limit the ability of
any one center to cope with the volume of images that need to be
read. As a result, patients benefit from faster diagnoses and
better-informed treatment plans.
“This latest collaboration with the NHS in Scotland further
demonstrates our commitment to deliver patient-centric solutions
designed to deliver the right information at the right time to help
improve the patient experience and help advance the path to
precision care,” said Kees Wesdorp, Chief Business Leader of
Precision Diagnosis at Philips. “The Scottish Breast Screening
Program has revolutionized breast cancer care in Scotland, ensuring
that no matter where patients live, they have a better chance of
receiving an early diagnosis and timely treatment. Philips is proud
to be working with the team at NHS Scotland to continually improve
the technology, scope and scale of the program.”
Philips’ diagnostic informatics portfolio supports hospitals and
imaging centers with intelligent, scalable, secure and
interoperable solutions which connect people, technology and data
to support clinical decisions at every point of care. Philips’
end-to-end portfolio of enterprise informatics solutions enables
patients, clinicians and hospital administrators to fully harness
the power of information and translate data into actionable
insights – a critical next step to advance precision care.
Philips will be showcasing its enterprise imaging solutions that
securely connect and facilitate the sharing of information among
patients and their care teams across health systems at the upcoming
HIMSS Global meeting, March 14 – March 18 in Orlando, Florida, USA.
For more information on how the company’s advanced analytics and
intelligent informatics support clinicians at the point-of-care by
providing clinical insights and improving collaboration among
clinical care teams, visit www.philips.com/himss and follow
@PhilipsLiveFrom for #HIMSS22 updates throughout the event.
[1] Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M,
Znaor A, Bray F. Cancer statistics for the year 2020: An overview.
Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588. Epub ahead of
print. PMID: 33818764. https://pubmed.ncbi.nlm.nih.gov/33818764/[2]
https://www.nhsinform.scot/healthy-living/screening/breast/breast-screening[3]
https://www.isdscotland.org/Health-topics/Cancer/Breast-screening/[4]
https://publichealthscotland.scot/publications/cancer-staging-data-using-2018-to-2020-dce-data-the-impact-of-covid-19/cancer-staging-data-using-2018-to-2020-dce-data-the-impact-of-covid-19/
For further information, please contact:
Kathy O’ReillyPhilips Global Press OfficeTel.: +1
978-221-8919E-mail: kathy.oreilly@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2021 sales of EUR 17.2 billion and
employs approximately 78,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Two doctors reviewing mammogram case
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Mar 2023 a Mar 2024